Filing Details
- Accession Number:
- 0001171843-15-000371
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-26 18:26:04
- Reporting Period:
- 2015-01-22
- Filing Date:
- 2015-01-26
- Accepted Time:
- 2015-01-26 18:26:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1234734 | Rajat Rai | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-22 | 150,000 | $1.46 | 1,480,220 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-22 | 70,656 | $41.26 | 1,409,564 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-22 | 554,988 | $2.61 | 1,964,552 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-22 | 269,954 | $41.26 | 1,694,598 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-23 | 397,189 | $6.62 | 2,091,787 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-23 | 216,929 | $42.10 | 1,874,858 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-23 | 195,012 | $2.61 | 2,069,870 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-23 | 97,446 | $42.10 | 1,972,424 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-26 | 402,811 | $6.62 | 2,375,235 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-26 | 219,000 | $42.55 | 2,156,235 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-22 | 150,000 | $0.00 | 150,000 | $1.46 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-22 | 554,988 | $0.00 | 554,988 | $2.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-23 | 397,189 | $0.00 | 397,189 | $6.62 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-23 | 195,012 | $0.00 | 195,012 | $2.61 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-01-26 | 402,811 | $0.00 | 402,811 | $6.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-22 | No | 4 | M | Direct | |
| 195,012 | 2015-05-21 | No | 4 | M | Direct | |
| 402,811 | 2016-04-29 | No | 4 | M | Direct | |
| 0 | 2015-05-21 | No | 4 | M | Direct | |
| 0 | 2016-04-29 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2014.
- All proceeds from the sale were used to cover exercise price and taxes due upon exercise of options.
- Upon execution of transactions disclosed on this Form 4, all securities subject to the 10b5-1 trading plan have been transacted and the plan has expired pursuant to its terms.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $40.80 to $42.24 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $41.59 to $42.65 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $41.92 to $43.11 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Amount of Shares Beneficially Owned Following Reported Transactions include 124,864 unvested shares subject to restricted stock awards and 2,031,371 shares owned outright. Shares owned outright include 1,015 shares acquired through participation in the Employee Stock Purchase Plan for the 2014 plan year.
- The option vested in three annual installments with 50,000 options vesting on each of February 22, 2011, February 22, 2012, and February 22, 2013.
- The option vested in three annual installments with 250,000 options vesting on each of May 21, 2011, May 21, 2012, and May 21, 2013.
- The options vested in annual installments with 266,666 options vesting on April 29, 2012, and 266,667 options vesting on each of April 29, 2013, and April 29, 2014.
- There was no consideration given in exchange for the security.
Billionaire Hedge Funds
